Compared to Estimates, ResMed (RMD) Q4 Earnings: A Look at Key Metrics

For the quarter ended June 2024, ResMed (RMD) reported revenue of $1.22 billion, up 9% over the same period last year. EPS came in at $2.08, compared to $1.60 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.21 billion, representing a surprise of +0.73%. The company delivered an EPS surprise of +2.46%, with the consensus EPS estimate being $2.03. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectatio ...